|
시장보고서
상품코드
2075123
소아용 백신 시장 : 백신 유형별, 기술별, 유형별, 유통 채널별 및 지역별Pediatric Vaccines Market, By Vaccine Type, By Technology, By Type, By Distribution Channel, and By Region |
||||||
소아용 백신 시장은 2026년에 552억 8,640만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 838억 4,660만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.1%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 552억 8,640만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 6.10% | 2033년 시장 규모 예측 : | 838억 4,660만 달러 |
예방접종은 보건 프로그램의 하나로, 10년마다 수천 명의 사망과 수백만 건의 질병을 예방하고, 수십억 달러의 비용을 절감하고 있습니다. 예방접종은 암, 장애, 사망을 포함한 질병으로부터 아이들을 보호하는 안전하고 효과적인 방법입니다. 팬데믹이나 그 밖의 공중보건 비상사태가 발생했을 때는 추가적인 감염 확산을 막기 위해 정기적인 예방접종을 꾸준히 받는 것이 중요합니다. 백신에는 성인용 백신이나 소아용 백신 등 연령대에 따라 다양한 유형이 있습니다. 소아용 백신은 출생시 접종되는 1차 접종입니다. 2차 접종은 생후 6주, 3차 접종은 생후 10주, 마지막 접종은 생후 14주에 실시됩니다. 이 백신은 신경계에 침투하여 전신 마비를 일으킬 가능성이 있는 전염성이 매우 강한 질병인 소아마비 바이러스로부터 몸을 보호해 줍니다.
시장 역학
규제 당국의 백신 승인 건수가 증가하고 있는 것이 예측 기간 중 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 2022년 6월 18일, 미국 질병통제예방센터(CDC)는 생후 6개월 이상의 영유아에 대한 COVID-19 백신 접종을 승인했습니다. 이로 인해 미국에서는 5세 미만 어린이 2,000만 명이 새롭게 백신 접종 대상에 포함되었습니다. 5세 미만의 어린이에게는 두 유형의 백신을 접종할 수 있습니다. 3회 접종하는 화이자 COVID-19 백신은 생후 6개월부터 4세까지의 어린이에게 3마이크로그램 용량으로 투여됩니다. 2회 접종하는 모더나사의 COVID-19 백신은 생후 6개월부터 5세까지의 어린이에게 25마이크로그램의 용량으로 권장됩니다.
주요 시장 참여자들은 COVID-19를 비롯한 감염병에 맞서기 위해, 다양한 기술을 활용한 백신 생산을 위한 연구개발 활동 강화에 주력하고 있습니다. 예를 들어 2022년 6월, 다국적 제약·바이오기술 기업인 화이자(Pfizer)와 바이오기술 기업인 바이오엔테크(BioNTech SE)는 오미크론 변이에 대응하는 두 가지 COVID-19 백신 후보(하나는 단가, 다른 하나는 2가)에 대해 안전성, 면역원성 및 내약성을 평가한 긍정적인 데이터를 발표했습니다. 화이자-바이오엔테크의 COVID-19 백신과 특정 백신 후보 물질의 병용 투여는 우려되는 오미크론 BA.1 변이주의 스파이크 단백질을 표적으로 삼고 있습니다. 2/3상 임상시험 데이터에 따르면 오미크론 변이에 대응하는 두 백신 후보를 이용한 부스터 접종은 양사가 현재 제공하고 있는 COVID-19 백신에 비해 오미크론 BA.1 변이에 대한 면역 반응이 현저히 높은 것으로 나타났습니다. 이러한 강력한 면역 반응은 30µg 및 60µg의 두 가지 시험 용량에서 확인되었습니다. BioNTech사의 독자적인 mRNA 기술을 기반으로 한 화이자-BioNTech COVID-19 백신은 BioNTech사와 화이자사의 공동 개발로 탄생했습니다.
본 연구의 주요 특징 :
- 이 연구는 다양한 부문에서 잠재적인 매출 기회를 밝혀내고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 소아용 백신 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 세계의 소아용 백신 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 소아용 백신 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 소아용 백신 시장 : 백신 유형별, 2021-2033년
제5장 세계의 소아용 백신 시장 : 기술별, 2021-2033년
제6장 세계의 소아용 백신 시장 : 유형별, 2021-2033년
제7장 세계의 소아용 백신 시장 : 유통 채널별, 2021-2033년
제8장 세계의 소아용 백신 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.07.07Pediatric Vaccines Market is estimated to be valued at USD 55,286.4 Mn in 2026 and is expected to reach USD 83,846.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 55,286.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.10% | 2033 Value Projection: | USD 83,846.6 Mn |
Immunizations is one of the public healthcare program for vaccination that prevents thousands of deaths, millions of cases of disease, and saves billions of dollars per decade. Immunizations are a safe, and effective way to protect children from disease including cancers, disability, and death. It is important during a pandemic or other public health emergency to maintain routine immunizations in order to prevent further outbreaks. There are various types of vaccines based on age group that include adult vaccines and pediatric vaccines. The pediatric vaccine is the first dose that is taken at birth. The next dose is taken when the child is 6 weeks old, the third dose at 10 weeks old, and the last dose at 14 weeks old. This vaccine protects against the poliovirus that is a highly infectious disease that invades the nervous system, and can lead to total paralysis.
Market Dynamics
Increasing approval of vaccines by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on June 18, 2022, the Centers for Disease Control and Prevention (CDC) has approved COVID-19 vaccination for young children of age least 6 months old that means 20 million children, in the U.S., that are under 5 years are newly eligible for vaccination. For children under 5, there are two vaccines available. The three-dose Pfizer COVID-19 vaccine is provided to children 6 months to 4 years of age at a 3 microgram dosage. The two-dose Moderna COVID-19 vaccine is recommended for children of age 6 months to 5 years at a dose of 25 micrograms.
Key market players are focusing on increasing research and development activities for producing vaccines that employs various technologies to combat infections such as COVID-19 and others. For instance, in June 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology, and BioNTech SE, a biotechnology company, announced positive data evaluating the safety, immunogenicity, and tolerability, of two Omicron-adapted COVID-19 vaccine candidates: one monovalent and the other bivalent. A combination of the Pfizer-BioNTech COVID-19 Vaccine and a vaccine candidate targets the spike protein of the Omicron BA.1 variant of concern. Data from the Phase 2/3 trial showed that a booster dose of both Omicron-adapted vaccine candidates has substantially higher immune response against Omicron BA.1, as compared to the companies' current COVID-19 vaccine. The robust immune response was seen in two investigational dose levels, 30 µg and 60 µg. The Pfizer-BioNTech COVID-19 Vaccine that is based on BioNTech's proprietary mRNA technology was developed by both BioNTech and Pfizer Inc.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Pediatric Vaccines Market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Panacea Biotec, Zydus Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, and Indian Immunologicals Ltd.
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric vaccines market
Detailed Segmentation:
- Global Pediatric Vaccines Market, By Vaccine Type (Revenue, USD Mn, 2021 - 2033)
- Pneumococcal Vaccine
- DTP Vaccine
- Rotavirus Vaccine
- MMR Vaccine
- Polio Vaccine
- Influenza Vaccine
- Hepatitis B Vaccine
- Meningococcal Vaccine
- Hib Vaccine
- Varicella Vaccine
- Global Pediatric Vaccines Market, By Technology (Revenue, USD Mn, 2021 - 2033)
- Live or Attenuated Vaccine
- Inactivated or Killed Vaccine
- Toxoid Vaccine
- Conjugate Vaccine
- Subunit Vaccine
- Recombinant Vaccine
- Global Pediatric Vaccines Market By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Global Pediatric Vaccines Market By Distribution Channel:
- Government
- Private
- Global Pediatric Vaccines Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- By Country:
- U.S.
- Canada
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country:
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country:
- Asia Pacific
- By Type:
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- By Type:
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Country/Region:
- Company Profiles
- GlaxoSmithKline Plc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi S.A.
- Panacea Biotec
- Zydus Cadila
- Emergent BioSolutions Inc.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Indian Immunologicals Ltd.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Technology
- Market Snapshot, By Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, and Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- PORTER€(TM)s Analysis
- Pricing Analysis (2022)
4. Global Pediatric Vaccines Market, By Vaccine Type, 2021€"2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Pneumococcal Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- DTP Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Rotavirus Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- MMR Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Polio Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Influenza Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Hepatitis B Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Meningococcal Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Hib Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Varicella Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
5. Global Pediatric Vaccines Market, By Technology, 2021€"2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Live or Attenuated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Inactivated or Killed Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Subunit Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Recombinant Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
6. Global Pediatric Vaccines Market, By Type, 2021 €" 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segments Trends
- Monovalent Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Multivalent Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
7. Global Pediatric Vaccines Market, By Distribution Channel, 2021 €" 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segments Trends
- Government
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
8. Global Pediatric Vaccines Market, By Region, 2021 €" 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022€"2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 €" 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- GlaxoSmithKline Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Panacea Biotec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Indian Immunologicals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
